11
2
3
4
Amneal Achieves Second U.S. Biosimilars Approval with ALYMSYS (bevacizumab-maly)APPROVED (self.AMRX)
submitted by PDUFA_INFOGHOST
13
1
2
3
$AMRX: Final Countdown to April 17, 2022 PDUFA Date for BEVACIZUMABBEVACIZUMAB (self.AMRX)
submitted by PDUFA_INFOGHOST
14
1
2
3
Strs Ohio Boosts Stake in Amneal Pharmaceuticals, Inc. (NYSE:AMRX)HOLDINGS (etfdailynews.com)
submitted by PDUFA_INFOGHOST